Currently available agents include interferon-alfa, lamivudine, and adefovir dipivoxil. A 12-month or longer course of interferon-alfa treatment or re-treatment achieves sustained biochemical ...

Nat Clin Pract Nephrol. 2006;2(3):136-148. Hypophosphatemia associated with primary hyperparathyroidism is usually of moderate severity; increased urinary phosphate excretion is balanced by ...